API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Complexation of metal ions by pentamethyldiethylenetriamine

Pentamethyldiethylenetriamine acts as a versatile ligand or catalyst in various polymerization reactions. It forms complexes with transition metals.

May 4,2026  API

Solubility Study of Cabozantinib S-malate

Cabozantinib S-malate inhibits MET phosphorylation and migration of MPNST cells, while at 5–10 μM, it significantly suppresses cell growth.

May 4,2026  API

Applications of Raloxifene

Raloxifene is a receptor modulator applied for postmenopausal osteoporosis and breast cancer prevention, which also exerts neuroprotective effects.

May 4,2026  API

Synthetic Method and Nucleophilic Aromatic Substitution of 3,4-Difluorobenzonitrile

3,4-Difluorobenzonitrile is primarily used as a synthetic raw material for pharmaceuticals, dyes, and liquid crystal materials.

May 4,2026  API

Levothyroxine: Standard Hormone Therapy for Hypothyroidism

Levothyroxine is a synthetic form of thyroxine used to treat hypothyroidism by replacing or supplementing deficient natural thyroid hormones.

May 4,2026  API

Synhtesis and Polymerization properties of 1-Ethynyl-1-cyclohexanol

As a tertiary alcohol, 1-Ethynyl-1-cyclohexanol can be prepared via the nucleophilic addition reaction of ethynyl Grignard reagent with cyclohexanone.

May 3,2026  API

Industrial Production and Chemical Properties of Methyl 4-chloropicolinate

Methyl 4-chloropicolinate can be prepared by the esterification reaction of the corresponding chlorinated pyridine carboxylic acid with methanol.

May 3,2026  API

Synthesis and Biological Activity of 5-Methyluridine

5-Methyluridine is primarily used as a biochemical synthesis reagent and a fundamental raw material in medicinal chemistry.

May 1,2026  API

Market Launch History and Pharmacological Effects of Florfenicol

Florfenicol is a new broad-spectrum veterinary antibacterial agent belonging to the chloramphenicol class, successfully developed in the late 1980s.

May 1,2026  API

Clinical Treatment Case and Assay Method of Aluminium glycinate

Aluminium glycinate provides rapid and sustained buffering action, preventing gastric mucosal damage caused by gastric acid.

May 1,2026  API
Prev12345678910...Next>  Go to Page